Alitretinoin Compliance in Patients with Chronic Hand Eczema.

Author: ChoGyeong Je, HongSeong Min, JinWoo Jung, JungSo Young, KimHyojin, KimJong Uk, ParkIn Ho, ParkSo Hee, SeolJung Eun

Paper Details 
Original Abstract of the Article :
BACKGROUND: Oral alitretinoin is effective in the treatment of chronic hand eczema (CHE), and ≥12 weeks of alitretinoin treatment has been shown to be effective in Korean patients. However, in the real world, a considerable number of patients discontinue alitretinoin, which leads to treatment failur...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875224/

データ提供:米国国立医学図書館(NLM)

The Challenges of Alitretinoin Compliance in Chronic Hand Eczema

Chronic hand eczema, a persistent and often debilitating skin condition, can significantly impact a patient's quality of life. This research explores the challenges associated with alitretinoin treatment, a medication known for its effectiveness in managing this condition. The study, much like a camel traversing a vast desert, navigates the complexities of real-world patient compliance with alitretinoin therapy. The authors shed light on the reasons for poor compliance, a crucial aspect that can hinder treatment success and leave patients vulnerable to the persistent effects of the disease.

Unveiling the Barriers to Compliance

The study reveals a significant number of patients discontinuing alitretinoin treatment before reaching the recommended 12-week duration. This finding highlights the importance of addressing the factors contributing to poor compliance. The authors delve into demographic factors, dosage patterns, and treatment efficacy, meticulously dissecting the reasons for treatment discontinuation. The study highlights that while alitretinoin is a powerful weapon in the fight against chronic hand eczema, its effectiveness is often hampered by factors like non-improvement, cost, and side effects.

Navigating the Treatment Landscape

This research underscores the importance of communication and education in patient care. Physicians need to proactively address patient concerns, provide clear explanations about alitretinoin's benefits and potential side effects, and develop strategies to overcome financial barriers. This approach, akin to a wise camel guiding travelers through the desert, can help patients navigate the treatment journey and maximize their chances of achieving long-term relief from chronic hand eczema.

Dr.Camel's Conclusion

This study offers a comprehensive look at the factors influencing alitretinoin compliance in patients with chronic hand eczema. The authors' findings emphasize the importance of addressing patient concerns, providing clear explanations, and tailoring treatment strategies to individual needs. This knowledge empowers physicians to provide optimal care and support to patients navigating the complexities of chronic hand eczema management.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-22
Further Info :

Pubmed ID

33911811

DOI: Digital Object Identifier

PMC7875224

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.